Presbia Stock Price, News & Analysis (NASDAQ:LENS)

$2.54 0.18 (7.63 %)
(As of 12/12/2017 04:00 PM ET)
Previous Close$2.36
Today's Range$2.28 - $2.56
52-Week Range$1.86 - $5.88
Volume7,667 shs
Average Volume16,679 shs
Market Capitalization$38.84 million
P/E RatioN/A
Dividend YieldN/A
Beta0.02

About Presbia (NASDAQ:LENS)

Presbia logoPresbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company's segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company's lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient's eye to improve that patient's ability to see objects at close distances. The microlens is a disc shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia and a central zone that is designed to improve distance vision. The Company's solution is a standalone solution for plano presbyopes, or those individuals suffering from presbyopia but do not have any other visual disorders.

Receive LENS News and Ratings via Email

Sign-up to receive the latest news and ratings for LENS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:LENS
CUSIPN/A
Phone353-659-9446

Debt

Debt-to-Equity Ratio0.07%
Current Ratio3.02%
Quick Ratio2.94%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$10,000.00
Price / Sales4,348.48
Cash FlowN/A
Price / CashN/A
Book Value$0.63 per share
Price / Book4.03

Profitability

Trailing EPS($1.20)
Net Income$-15,750,000.00
Net MarginsN/A
Return on Equity-173.64%
Return on Assets-137.41%

Miscellaneous

Employees40
Outstanding Shares17,120,000

Presbia (NASDAQ:LENS) Frequently Asked Questions

What is Presbia's stock symbol?

Presbia trades on the NASDAQ under the ticker symbol "LENS."

How were Presbia's earnings last quarter?

Presbia PLC (NASDAQ:LENS) posted its quarterly earnings data on Friday, August, 12th. The medical instruments supplier reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.25) by $0.07. The medical instruments supplier had revenue of $0.01 million for the quarter, compared to the consensus estimate of $0.04 million. View Presbia's Earnings History.

When will Presbia make its next earnings announcement?

Presbia is scheduled to release their next quarterly earnings announcement on Friday, December, 15th 2017. View Earnings Estimates for Presbia.

Where is Presbia's stock going? Where will Presbia's stock price be in 2017?

3 equities research analysts have issued 1-year price objectives for Presbia's shares. Their predictions range from $10.00 to $12.00. On average, they expect Presbia's stock price to reach $11.33 in the next year. View Analyst Ratings for Presbia.

Who are some of Presbia's key competitors?

Who are Presbia's key executives?

Presbia's management team includes the folowing people:

  • Ralph H. Thurman, Executive Chairman of the Board (Age 67)
  • Todd Cooper, President, Chief Executive Officer, Director (Age 50)
  • Jarett Fenton, Chief Financial Officer, Secretary (Age 39)
  • John Strobel, Vice President of Sales
  • Gerd Auffarth M.D., Ph.D., Director
  • Robert J. Cresci, Director (Age 73)
  • Gerald Farrell Ph.D., Director
  • Vladimir Feingold, Director (Age 66)
  • Zohar Loshitzer, Director (Age 57)

When did Presbia IPO?

(LENS) raised $50 million in an initial public offering on Thursday, January 29th 2015. The company issued 4,200,000 shares at $11.00-$13.00 per share. Jefferies acted as the underwriter for the IPO.

How do I buy Presbia stock?

Shares of Presbia can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Presbia's stock price today?

One share of Presbia stock can currently be purchased for approximately $2.54.

How big of a company is Presbia?

Presbia has a market capitalization of $38.84 million and generates $10,000.00 in revenue each year. The medical instruments supplier earns $-15,750,000.00 in net income (profit) each year or ($1.20) on an earnings per share basis. Presbia employs 40 workers across the globe.

How can I contact Presbia?

Presbia's mailing address is 120/121 BAGGOT STREET LOWER, DUBLIN 2 L2, . The medical instruments supplier can be reached via phone at 353-659-9446.


MarketBeat Community Rating for Presbia (LENS)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  61 (Vote Outperform)
Underperform Votes:  78 (Vote Underperform)
Total Votes:  139
MarketBeat's community ratings are surveys of what our community members think about Presbia and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Presbia (NASDAQ:LENS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $11.33$11.33$12.00$12.00
Price Target Upside: 116.50% upside116.50% upside346.11% upside346.11% upside

Presbia (NASDAQ:LENS) Consensus Price Target History

Price Target History for Presbia (NASDAQ:LENS)

Presbia (NASDAQ:LENS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/6/2017Jefferies GroupReiterated RatingBuy$11.00 -> $10.00N/AView Rating Details
5/23/2017HC WainwrightReiterated RatingBuy$12.00LowView Rating Details
5/22/2017Rodman & RenshawLower Price TargetBuy -> Buy$14.00 -> $12.00MediumView Rating Details
(Data available from 12/12/2015 forward)

Earnings

Presbia (NASDAQ:LENS) Earnings History and Estimates Chart

Earnings by Quarter for Presbia (NASDAQ:LENS)

Presbia (NASDAQ LENS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/15/2017        
8/12/2016Q3 2016($0.25)($0.32)$0.04 million$0.01 millionViewN/AView Earnings Details
3/25/2016Q2($0.26)($0.29)$0.04 million$0.03 millionViewN/AView Earnings Details
8/6/2015Q2 2015($0.29)($0.40)$0.40 million$0.04 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Presbia (NASDAQ:LENS) Earnings Estimates

2018 EPS Consensus Estimate: ($1.24)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.24)($0.24)($0.24)
Q2 20181($0.26)($0.26)($0.26)
Q3 20181($0.35)($0.35)($0.35)
Q4 20181($0.39)($0.39)($0.39)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Presbia (NASDAQ:LENS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Presbia (NASDAQ LENS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 74.70%
Institutional Ownership Percentage: 16.05%
Insider Trades by Quarter for Presbia (NASDAQ:LENS)
Insider Trades by Quarter for Presbia (NASDAQ:LENS)

Presbia (NASDAQ LENS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/17/2016Gerald FarrellDirectorBuy5,000$4.65$23,250.00View SEC Filing  
12/17/2015Richard S ResslerDirectorBuy500$6.00$3,000.00View SEC Filing  
12/10/2015Richard S. ResslerDirectorBuy499$6.00$2,994.00View SEC Filing  
12/2/2015Richard S. ResslerDirectorBuy1,300$5.86$7,618.00View SEC Filing  
11/25/2015Randy H ThurmanChairmanBuy1,833$5.45$9,989.85View SEC Filing  
11/24/2015Richard S ResslerDirectorBuy2,300$4.97$11,431.00View SEC Filing  
11/20/2015Richard FogartyCAOBuy1,000$4.00$4,000.00View SEC Filing  
11/19/2015Robert J. CresciDirectorBuy10,000$3.97$39,700.00View SEC Filing  
11/19/2015Zohar LoshitzerInsiderBuy5,500$4.00$22,000.00View SEC Filing  
11/18/2015Todd CooperCEOBuy7,500$3.99$29,925.00View SEC Filing  
5/26/2015Richard FogartyCAOBuy1,000$8.60$8,600.00View SEC Filing  
5/20/2015Randy H ThurmanChairmanBuy11,110$8.96$99,545.60View SEC Filing  
2/3/2015Richard S ResslerDirectorBuy500,000$10.00$5,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Presbia (NASDAQ LENS) News Headlines

Source:
DateHeadline
Financial Contrast: Viewray (VRAY) versus Presbia (LENS)Financial Contrast: Viewray (VRAY) versus Presbia (LENS)
www.americanbankingnews.com - December 10 at 9:08 PM
Presbia (LENS) Stock Rating Upgraded by Zacks Investment ResearchPresbia (LENS) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - December 10 at 6:34 PM
Comparing Mazor Robotics (MZOR) and Presbia (LENS)Comparing Mazor Robotics (MZOR) and Presbia (LENS)
www.americanbankingnews.com - December 4 at 12:02 PM
Zacks: Brokerages Anticipate Presbia PLC (LENS) Will Post Earnings of -$0.26 Per ShareZacks: Brokerages Anticipate Presbia PLC (LENS) Will Post Earnings of -$0.26 Per Share
www.americanbankingnews.com - November 27 at 9:14 AM
Brokerages Anticipate Presbia PLC (LENS) to Post ($0.26) Earnings Per ShareBrokerages Anticipate Presbia PLC (LENS) to Post ($0.26) Earnings Per Share
www.americanbankingnews.com - November 26 at 3:18 PM
ETFs with exposure to Presbia Plc : November 21, 2017ETFs with exposure to Presbia Plc : November 21, 2017
finance.yahoo.com - November 22 at 1:50 AM
Analyzing Presbia PLC (LENS) & Digirad Corporation (DRAD)Analyzing Presbia PLC (LENS) & Digirad Corporation (DRAD)
www.americanbankingnews.com - November 16 at 10:18 AM
Presbia PLC (LENS) and Hologic (HOLX) Head-To-Head ContrastPresbia PLC (LENS) and Hologic (HOLX) Head-To-Head Contrast
www.americanbankingnews.com - October 14 at 8:14 AM
Presbia PLC to Post Q1 2018 Earnings of ($0.24) Per Share, Jefferies Group Forecasts (LENS)Presbia PLC to Post Q1 2018 Earnings of ($0.24) Per Share, Jefferies Group Forecasts (LENS)
www.americanbankingnews.com - October 9 at 4:48 AM
Presbia PLCs (LENS) "Buy" Rating Reiterated at Jefferies Group LLCPresbia PLC's (LENS) "Buy" Rating Reiterated at Jefferies Group LLC
www.americanbankingnews.com - October 6 at 1:46 PM
ECYT On Fire After ABX Deal, Rigels ITP Drug Skips Panel Review, MCRB On WatchECYT On Fire After ABX Deal, Rigel's ITP Drug Skips Panel Review, MCRB On Watch
www.rttnews.com - October 2 at 10:01 PM
Should You Be Holding Presbia PLC (LENS) Right Now?Should You Be Holding Presbia PLC (LENS) Right Now?
finance.yahoo.com - October 2 at 10:01 PM
Head-To-Head Review: Presbia PLC (LENS) versus Alliance HealthCare Services (AIQ)Head-To-Head Review: Presbia PLC (LENS) versus Alliance HealthCare Services (AIQ)
www.americanbankingnews.com - September 25 at 4:10 PM
Head to Head Survey: Presbia PLC (LENS) vs. The CompetitionHead to Head Survey: Presbia PLC (LENS) vs. The Competition
www.americanbankingnews.com - September 20 at 2:22 PM
Analyzing Presbia PLC (LENS) & The CompetitionAnalyzing Presbia PLC (LENS) & The Competition
www.americanbankingnews.com - September 16 at 4:24 AM
Presbia to Participate in Rodman & Renshaw 19th Annual Global Investment ConferencePresbia to Participate in Rodman & Renshaw 19th Annual Global Investment Conference
finance.yahoo.com - September 8 at 1:16 AM
ETFs with exposure to Presbia Plc : August 1, 2017ETFs with exposure to Presbia Plc : August 1, 2017
finance.yahoo.com - August 2 at 3:04 AM
ETFs with exposure to Presbia Plc : July 3, 2017ETFs with exposure to Presbia Plc : July 3, 2017
finance.yahoo.com - July 3 at 7:51 PM
6:15 pm Presbia extends shareholder rights offering for up to 4.5 mln ordinary shares to March 8 from February 236:15 pm Presbia extends shareholder rights offering for up to 4.5 mln ordinary shares to March 8 from February 23
us.rd.yahoo.com - February 23 at 11:16 PM
PRESBIA PLC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsPRESBIA PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
us.rd.yahoo.com - February 22 at 6:24 PM
Presbia Announces Extension of Rights OfferingPresbia Announces Extension of Rights Offering
uk.finance.yahoo.com - February 22 at 6:24 PM
Form 424B4 Presbia PLCForm 424B4 Presbia PLC
www.streetinsider.com - January 27 at 8:27 PM
Presbia Announces Price and Key Dates Related to Rights OfferingPresbia Announces Price and Key Dates Related to Rights Offering
uk.finance.yahoo.com - January 26 at 8:01 PM
Presbia (LENS) Unit Completes Acquisition of Neoptics AGPresbia (LENS) Unit Completes Acquisition of Neoptics AG
www.streetinsider.com - August 22 at 10:31 AM
PRESBIA PLC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersPRESBIA PLC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - August 10 at 8:54 AM
PRESBIA PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or DispositionPRESBIA PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition
biz.yahoo.com - August 8 at 6:09 PM
Presbia to Participate in the 2016 Australasian Society of Cataract and Refractive Surgeons 20 th Annual ConferencePresbia to Participate in the 2016 Australasian Society of Cataract and Refractive Surgeons 20 th Annual Conference
www.businesswire.com - July 12 at 10:20 AM
Heres Why Presbia Is Worth $14/Share, Despite Plummeting MondayHere's Why Presbia Is Worth $14/Share, Despite Plummeting Monday
feeds.benzinga.com - May 23 at 1:49 PM
Rodman & Renshaw Initiates Unsung Presbia With Buy; Stock JumpsRodman & Renshaw Initiates 'Unsung' Presbia With Buy; Stock Jumps
feeds.benzinga.com - May 10 at 2:56 PM
PRESBIA PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsPRESBIA PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
biz.yahoo.com - May 2 at 5:05 PM
PRESBIA PLC Files SEC form 10-K, Annual ReportPRESBIA PLC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 28 at 6:03 AM

SEC Filings

Presbia (NASDAQ:LENS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Presbia (NASDAQ:LENS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Presbia (NASDAQ LENS) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.